Search results
Hospital COVID patients 35% more likely to die than flu patients last winter, study suggests
Center for Infectious Disease Research and Policy· 16 hours agoThe study period included the emergence of the JN.1 SARS-CoV-2 variant in December 2023. Follow-up...
Experts blast CDC over failure to test sewage for signs of H5N1 bird flu virus
Los Angeles Times· 6 days agoIt emerged as a powerful tool for public health officers during the COVID-19 pandemic, when it was...
Earnings call: Invivyd optimistic about PEMGARDA's market potential
Investing.com· 3 days agoInvivyd, a biotechnology company, recently held an earnings call to discuss their first-quarter...
Study: Before vaccines, 44% of COVID-19 patients in ICU died
Center for Infectious Disease Research and Policy· 13 hours agoThe study was published yesterday in Emerging Infectious Diseases and is based on 2,479,423 cases...
We invest in our military to prevent attacks — why not also invest in preventing the next pandemic?
The Hill· 21 hours agoHow should we be preparing for the next pandemic? Given the economic impact that COVID-19 had, any...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
Digital Journal· 2 days agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven mechanisms that contribute to the broad efficacy of the vaccine candidate Significant milestone ...
Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024
Journal of the American Medical Association· 1 day agoThis cohort study evaluates the risk of death in patients hospitalized for COVID-19 or seasonal influenza following the emergence of the JN.1 variant in winter 2023.
Expert reaction: AstraZeneca withdraws its COVID-19 vaccine
Cosmos· 5 days agoAstraZeneca developed the first vaccine for COVID-19, beating the competition, but this week they’ve...
A small summer Covid wave may be ahead, experts say, as a new variant takes over
AOL· 5 days agoDisease experts anticipate a small uptick in Covid cases this summer, as a new variant spreads. The KP.2 variant represents 28% of Covid infections in the U.S., up from just ...
Earnings call: Virios Therapeutics reports on Q1 2024 progress
Investing.com· 4 days agoVirios Therapeutics ( NASDAQ : VIRI) discussed their first quarter financial results and provided an...